Resonetics announced that it has begun an agreement to acquire Resolution Medical, a provider of integrated design and manufacturing solutions for complex medical devices.

Resolution Medical is based in Fridley, Minn. with further operations in the Netherlands. It’s currently owned by Arcline Investment Management.

The deal adds complementary capabilities in markets including neuromodulation, structural heart, and interventional cardiology to Resonetics’ offerings. The acquisition is expected to close in 2026, pending regulatory approvals and customary closing conditions.

“Resolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices for the most innovative companies,” said Kevin Kelly, CEO of Resonetics. “This acquisition will enhance our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart and supports our vision of becoming the most comprehensive partner in the medical device industry.”

Resolution Medical brings more than 240 employees, including over 100 engineers, and a strong reputation for delivering high-quality design engineering, new product introduction (NPI), and cleanroom production capabilities. The company supports a wide range of Class II and III devices and has built deep customer relationships, particularly in the neuromodulation and structural heart markets.

“This acquisition represents the ideal outcome for our customers and for our employees. Our customers will benefit from access to deeper capabilities and a more integrated, expansive partner,” said Peter Herman, CEO of Resolution Medical. “By joining Resonetics, our employees also gain access to the skills, resources, and opportunities of a larger organization. Resolution Medical will be able to operate at greater scale and deliver enhanced solutions to our customers while continuing to support their programs with the same teams, expertise, and commitment they rely on today.”

Earlier this month, acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally.